首页 | 本学科首页   官方微博 | 高级检索  
检索        


Entecavir combined with interferon-α Is superior to entecavir monotherapy in reducing hepatic and extrahepatic cancer in patients with chronic hepatitis B
Authors:Kailiang Cheng PhD  Yu Chen MD  Xiaomo Wang PhD  Manman Xu MD  Wei Liao PhD  Xiaoman Duan PhD  Xinyu Zhao PhD  Yuanyuan Sun PhD  Zhongping Duan MD  Li Wang PhD
Institution:1. Department of Epidemiology and Biostatistics, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences/School of Basic Medicine, Peking Union Medical College, Beijing, China;2. Fourth Department of Liver Disease (Difficult and Complicated Liver Diseases and Artificial Liver Center), Beijing You'an Hospital, Capital Medical University, Beijing, China

Beijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment Research, Beijing, China;3. Sam Houston State University, Huntsville, Texas;4. Fourth Department of Liver Disease (Difficult and Complicated Liver Diseases and Artificial Liver Center), Beijing You'an Hospital, Capital Medical University, Beijing, China

Abstract:
Keywords:entecavir  extrahepatic cancers  hepatocellular carcinoma  interferon  real-world studies
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号